Effectiveness of Cognitive Behavioral Therapy for Depression and Anxiety in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis
Authors:
- Michael HopkinsonMHMichael Hopkinson
- Danielle ClarkesmithDCDanielle Clarkesmith
- Deirdre A. LaneDLDeirdre A. Lane
- 1 October 2018
- journal article
- review article
- Published by Wolters Kluwer Health in Psychosomatic Medicine
- Vol. 80 (8) , 742-753
Abstract
Objective: Depression and anxiety are highly prevalent in patients with cardiovascular disease (CVD) and influence their mental well-being and CVD prognosis. The primary objective was to assess the effectiveness of cognitive behavioral therapy (CBT) for depression and anxiety in patients with CVD. Secondary objectives were to assess the impact of CBT on cardiovascular mortality, cardiovascular events, patient satisfaction, and quality of life. Methods: MEDLINE, PsycINFO, CINAHL, CENTRAL, and alternative sources were searched for randomized controlled trials and observational studies with a control. Studies were required to assess CBT in coronary heart disease, acute coronary syndrome, atrial fibrillation, or postmyocardial infarction patients, with anxiety and/or depression. Studies were independently screened by two reviewers and critically appraised using the Cochrane Risk of Bias tool. The random-effects model was used to pool standardized mean differences (SMD). Results: Twelve randomized controlled trials were included. At follow-up, depression (SMD = −0.35, 95% confidence interval [CI] = −0.52 to −0.17, p < .001, I 2 = 59%) and anxiety (SMD = −0.34, 95% CI = −0.65 to −0.03, p = .03, I 2 = 71%) scores were significantly lower in CBT patients compared with controls. Change in mental health quality of life (SF-12) was also significantly greater for CBT patients, compared with controls (mean difference = 3.62, 95% CI = 0.22 to 7.02, p = .04, I 2 = 0%). No differences in patient satisfaction or cardiovascular events were evident between CBT and control groups. Among the study reports included in this meta-analysis, data specific to cardiovascular mortality were not reported. Conclusions: Cognitive behavioral therapy seems to be an effective treatment for reducing depression and anxiety in patients with CVD and should be considered in standard clinical care.Keywords
This publication has 31 references indexed in Scilit:
- Randomised controlled trial of group cognitive behaviour therapy versus brief intervention for depression in cardiac patientsAustralian & New Zealand Journal of Psychiatry, 2012
- The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analysesCognitive Therapy and Research, 2012
- European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)European Heart Journal, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Randomized controlled trial of brief cognitive behavioral intervention for depression and anxiety symptoms preoperatively in patients undergoing coronary artery bypass graft surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Evaluating the Angina Plan in Patients Admitted to Hospital with Angina: A Randomized Controlled TrialCardiovascular Therapeutics, 2011
- Enhanced Depression Care for Patients With Acute Coronary Syndrome and Persistent Depressive SymptomsArchives of internal medicine (1960), 2010
- Depression in Heart FailureJACC, 2006
- Prospective Examination of Anxiety Persistence and Its Relationship to Cardiac Symptoms and Recurrent Cardiac EventsPsychotherapy and Psychosomatics, 2004
- Grading quality of evidence and strength of recommendationsBMJ, 2004